Cargando…
Radiation countermeasure agents: an update (2011 – 2014)
INTRODUCTION: Despite significant scientific advances over the past 60 years towards the development of a safe, nontoxic and effective radiation countermeasure for the acute radiation syndrome (ARS), no drug has been approved by the US FDA. A radiation countermeasure to protect the population at lar...
Autores principales: | Singh, Vijay K, Newman, Victoria L, Romaine, Patricia LP, Wise, Stephen Y, Seed, Thomas M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4438421/ https://www.ncbi.nlm.nih.gov/pubmed/25315070 http://dx.doi.org/10.1517/13543776.2014.964684 |
Ejemplares similares
-
Medical countermeasures for unwanted CBRN exposures: part II radiological and nuclear threats with review of recent countermeasure patents
por: Singh, Vijay K., et al.
Publicado: (2016) -
Biologics as countermeasures for acute radiation syndrome: where are we now?
por: Singh, Vijay K, et al.
Publicado: (2015) -
THE POTENTIATION OF THE RADIOPROTECTIVE EFFICACY OF TWO MEDICAL COUNTERMEASURES, GAMMA-TOCOTRIENOL AND AMIFOSTINE, BY A COMBINATION PROPHYLACTIC MODALITY
por: Singh, Vijay K., et al.
Publicado: (2016) -
Progenitors Mobilized by Gamma-Tocotrienol as an Effective Radiation Countermeasure
por: Singh, Vijay K., et al.
Publicado: (2014) -
Progenitor Cell Mobilization by Gamma-tocotrienol: A Promising Radiation Countermeasure
por: Singh, Vijay K., et al.
Publicado: (2016)